| Financial Year |
March 31 2023 |
| Monetary Funds |
3,721,908,526.00 |
| Held-for-trading Financial Assets |
5,135,522,948.00 |
| Notes Receivable |
40,733,086.00 |
| Accounts Receivable |
15,470,246,079.00 |
| Advances to Suppliers |
229,390,836.00 |
| Other Receivables |
128,658,017.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,833,314,886.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,631,095,890.00 |
| Other Current Assets |
783,072,454.00 |
| Total Current Assets |
30,055,956,065.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
999,317,731.00 |
| Investment Properties |
-- |
| Fixed Assetes |
38,826,938,158.00 |
| Under-construction Projects |
2,606,162,812.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
651,903,770.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,754,939,304.00 |
| Deferred Income Tax Assets |
101,049,202.00 |
| Other Non-Current Assets |
851,586,702.00 |
| Sub-Total of Non-Current Assets |
46,621,268,902.00 |
| Total Assets |
76,677,224,967.00 |
| Short-Term Loans |
5,859,881,098.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
9,961,165,667.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,367,930,136.00 |
| Taxes Payable |
436,905,465.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
310,182,634.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,185,190,478.00 |
| Other Current Liabilities |
737,145,905.00 |
| Sub-Total of Current Liabilities |
20,521,149,335.00 |
| Long-term Loans |
2,326,481,296.00 |
| Bonds Payable |
11,949,268,014.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,625,093.00 |
| Deferred Income Tax Liabilities |
232,739,306.00 |
| Other Non-Current Liabilities |
392,819,786.00 |
| Sub-Total of Non-Current Liabilities |
15,719,749,578.00 |
| Total Liabilities |
36,240,898,913.00 |
| Paid-In Capital(Or Share Stock) |
4,771,592,000.00 |
| Capital Surplus |
12,366,274,941.00 |
| Surplus Reserve |
2,508,655,960.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
20,740,742,799.00 |
| Minority Stockholder's Interest |
616,231,904.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,820,094,150.00 |
| Owner's Equity（Stockholder's Equity） |
40,436,326,054.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
76,677,224,967.00 |
